Many cell surface proteins are anchored to the membrane via a glycosylphosphatidylinositol (GPI) moiety, which is attached to the C terminus of the proteins. The core of the GPI anchor is conserved in all eukaryotes but is modified by various side chains. We cloned a mouse phosphatidylinositol glycan-class N (Pig-n) gene that encodes a 931amino acid protein expressed in the endoplasmic reticulum, which is homologous to yeast Mcd4p. We disrupted the gene in F9 embryonal carcinoma cells. In the Pig-n knockout cells, the first mannose in the GPI precursors was not modified by phosphoethanolamine. Nevertheless, further biosynthetic steps continued with the addition of the third mannose and the terminal phosphoethanolamine. The surface expression of Thy-1 was only partially affected, indicating that modification of the first mannose by phosphoethanolamine is not essential for attachment of GPI anchors in mammalian cells. An inhibitor of GPI biosynthesis, YW3548/ BE49385A, inhibited transfer of phosphoethanolamine to the first mannose in mammalian cells but only slightly affected the surface expression of GPI-anchored proteins. Biosynthesis of GPI in the Pig-n knockout cells was not affected by YW3548/BE49385A, and yeast overexpressing MCD4 was highly resistant to YW3548/ BE49385A, suggesting that Pig-n and Mcd4p are targets of this drug.
essential for growth and consists of a hydrophilic N-terminal lumenal domain and multiple transmembrane domains (13) . The three homologous yeast proteins have similar domain organization and regions conserved in phosphodiesterases and nucleotide pyrophosphatases within the N-terminal lumenal domain (12, 13) . Therefore, it is likely that they are involved in transfer of EtNP to each of the three mannoses.
A terpenoid lactone compound, YW3548, a fungal product, inhibits modification of Man1 with EtNP and inhibits GPI anchoring and growth of yeast (8, 14) . YW3548 does not inhibit GPI synthesis in protozoa, such as Trypanosoma brucei, Leishmania major and Plasmodium falciparum (14) , which is consistent with reports that their GPIs are not modified by EtNP on Man1 (1) . The compound also inhibits mammalian GPI synthesis (14) . It is likely that Mcd4p and its mammalian homologue are targets of YW3548.
Here, we report molecular cloning of a mouse MCD4 homologue termed phosphatidylinositol glycan-class N (Pig-n) and show that Pig-n is involved in the addition of EtNP to Man1 but that its modification is not essential for the surface expression of GPI-anchored proteins. We also demonstrate that YW3548 acts at the same step as Pig-n and affects the surface expression of GPI-anchored proteins on mammalian cells only slightly.
EXPERIMENTAL PROCEDURES
Cells and Reagents-Mouse embryonal carcinoma F9 cells were obtained from the American Type Culture Collection and cultured in Dulbecco's modified Eagle's medium supplemented with 15% fetal calf serum on 0.1% gelatin-coated dishes. Mouse GPI-deficient class B (15) and F (16) mutant lymphoma cells S1A (Thy-1 Ϫ b) and EL4 (Thy-1 Ϫ f) were gifts from Dr. R. Hyman (Salk Institute, San Diego, CA). Human B-lymphoblastoid cell line JY25 (17) was a gift from Dr. M. L. Shin (University of Maryland School of Medicine). They were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. Lec35.2 cells (18) were a gift from Dr. M. A. Lehrman (Texas Southwestern Medical Center, Dallas, TX) and were cultured in Ham's F-12 medium supplemented with 10% fetal calf serum. Dioctanoyl * This work was supported by grants from the Human Frontier Science program and the Ministry of Education, Science, Sports and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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Preparation of cDNA and Genomic Clones of Pig-n-We searched the GenBank TM data base using BLAST software (20) for sequences homologous to yeast Mcd4p (YKL165C) and found a mouse AA267602 sequence. The predicted amino acid sequence of mouse Mcd4p homologue was not a full coding sequence. To obtain a full sequence, we designed two primers, 5Ј-GGACTTCTTTGATGCTGCAAGAAACAAC (forward) and 5Ј-CCCAGTCTGTCATTCCATGGTCAGAGGT (reverse) on the basis of mouse AA267602 sequence and amplified a fragment from a mouse testis cDNA library. Sequences of PCR products were homologous to the human MCD4 homologue. Using a forward primer designed in a vector and a reverse primer, fragments containing the 5Ј region of mouse MCD4 homologue were amplified and cloned from the cDNA library. The longest clone was 1.2 kb long. Using a forward primer and a reverse vector primer, three fragments containing the 3Ј region were cloned. Two gave longer fragments of a similar size, and the third gave a shorter fragment. The longest 5Ј and longer 3Ј fragments were ligated to generate a full-length cDNA. We termed the mouse MCD4 homologue Pig-n.
To obtain genomic clones of Pig-n, we screened 1 ϫ 10 6 pfu of genomic FIXII library from a mouse 129/SvJ liver (Stratagene) using a 1.2-kb fragment containing the 5Ј region of Pig-n cDNA as a probe. We obtained 14 positive clones and restriction-mapped and sequenced the regions around the exons.
Disruption of Pig-n Gene in F9 Cells-A 7.2-kb XhoI-EcoRI genomic fragment of Pig-n, containing exons 10 -14, was transferred to pPNT (21) , and the resulting plasmid was named pPNT-L. A 3-kb NotI-XbaI genomic fragment of Pig-n containing exon 7 and a 1.9-kb XbaI-XhoI fragment of PGKneo or a 1.8-kb XbaI-XhoI fragment of PGKpuro were ligated together in the XbaI-NotI site in pPNT-L. The resulting plasmids were used as the first and second targeting vectors to delete exons 8 and 9. The gene targeting strategy was followed as described (22) . F9 cells (2 ϫ 10 7 ) were electroporated with 50 g of NotI-cut targeting vector at 230 V and 500 microfarads using a GenePulser (Bio-Rad) and seeded on plates coated with 0.1% gelatin. Positive selection was started with 380 g/ml G418 or 2 g/ml puromycin the next day. Three days later, negative selection with 2 M gancyclovir was performed. 8 -11 days after transfection, we screened colonies by PCR for recombinants, in which PCR primers, one in PGKneo or PGKpuro region and another in Pig-n, were used. Positive colonies were confirmed by Southern blot analysis.
Fluorescence-activated Cell Sorter Analysis-To examine the surface expression of GPI-anchored proteins, cells were stained with biotinylated anti-Thy1 G7 antibody (23) for F9 cells, and anti-CD59 5H8 antibody (24) or anti-DAF IA10 antibody (25) for JY25, followed by phycoerythrin-conjugated streptavidin (Biomedica). They were analyzed in a FACScan (Becton Dickinson). Biotinylated monoclonal rat IgG2c and mouse anti-HEL HybC2 (IgG1) antibodies were used as isotype controls.
In Vivo Mannose Labeling and Characterization of Glycolipids-F9 cells (10 6 ) grown in a gelatin-coated six-well plate overnight were incubated for 1 h in a medium containing 20 mM Hepes/NaOH (pH 7.4), 100 g/ml glucose, 10% dialyzed fetal calf serum, 10 g/ml tunicamycin, and penicillin/streptomycin and then incubated in the same medium containing 40 Ci/ml [ 3 H] mannose for 45 min (10) . After washing with phosphate-buffered saline, lipids were extracted, followed by partition into n-butanol (10) .
To study the effect of YW3548/BE49385A on GPI synthesis in mammalian cells, cells were incubated overnight in a medium containing 10 M YW3548/BE49385A, followed by mannose labeling and lipid extraction, as described above.
Glycolipids were separated on Kiesel gel 60 (Merck, Darmstadt, Germany) with a solvent system of chloroform:methanol:water (10:10:3) and detected by a Fuji BAS1500 image analyzer (Fuji Film Co., Tokyo, Japan) or x-ray film. In some cases, the glycolipids were treated with GPI-specific phospholipase D (GPI-PLD) (26) and jack bean ␣-mannosidase (Sigma) before TLC analysis.
In Vitro Mannose Labeling of Microsomes-Microsomes were prepared from 2 ϫ 10 7 cells treated with 5 g/ml tunicamycin for 5 h. For this, cells were lysed hypotonically in 20 mM HEPES/NaOH (pH 7.4) and homogenized. Supernatant after 10,000 ϫ g centrifugation were spun at 100,000 ϫ g for 1 h, and the membranes were resuspended in 50 l of Buffer A (50 mM HEPES/NaOH (pH 7.4), 25 mM KCl, 0.1 mM TLCK and 1 g/ml leupeptin) and stored at Ϫ80°C until use. The microsomes (50 l) were incubated with 50 l of reaction Buffer B (100 mM HEPES/NaOH (pH 7.4), 50 mM KCl, 15 mM MgCl 2 , 15 mM MnCl 2, 3 mM AMP, 30 M palmitoyl CoA, 3 g/ml tunicamycin, 0.2 mM TLCK, and 2 g/ml leupeptin) and 50 l (2 Ci) of GDP-[ 3 H]mannose (American Radiolabeled Chemicals, St. Louis, MO) for 1 h at 37°C. A synthetic substrate, GlcN-PI(C8), was dissolved in 0.03% Triton X-100 (19) , and 100 ng was added to the reaction.
Subcellular Localization of Pig-n-Pig-n knockout F9 cells were stably transfected with a cDNA of GST-tagged Pig-n (22) . Biosynthesis of GPI in the transfectant cells was restored to normal, indicating that the tagged protein was functional. Transfectant cells (3 ϫ 10 8 ) were lysed in a solution consisting of 0.25 M sucrose, 10 mM HEPES/NaOH (pH 7.4), 1 mM dithiothreitol, 0.1 mM TLCK, and 1 g/ml leupeptin by homogenization. After treatment with 1 g/ml DNase I for 20 min on ice, unbroken cells and nuclei were removed by centrifugation at 1000 ϫ g for 10 min. The supernatants were further separated into pellets (P10) and supernatants by centrifugation at 10,000 ϫ g for 10 min. Supernatants after 10,000 ϫ g centrifugation were centrifuged at 100,000 ϫ g for 1 h and separated into pellets (P100) and supernatants (S100). Pellets were dissolved in 1% Nonidet P-40 and 150 mM NaCl. Nonidet P-40 was also added to S100 to 1%. GST-tagged Pig-n was precipitated with glutathione-Sepharose beads and Western-blotted against anti-GST antibodies (22) .
In some experiments, P100 fractions were further separated with sucrose density gradient centrifugation as described. Membranes were collected from subfractions by centrifugation at 100,000 ϫ g for 2 h and dissolved in 1% Nonidet P-40 and 150 mM NaCl. GST-tagged Pig-n was assessed as above. Subfractions were characterized by assaying membrane marker enzymes, alkaline phosphodiesterase I for the plasma membrane, ␣-mannosidase II for the Golgi, and dolichol phosphate mannose synthase for the ER, as described (27) .
Assay for YW3548/BE49385A Sensitivity of Yeast Overexpressing MCD4 -pGal-MCD4 was constructed with the full-length MCD4 coding sequence (28) amplified from genomic DNA by PCR with Pfu polymerase (Stratagene) and the primers (upstream) 5Ј-CAAAGCATT-CTAGAGCCTTAGG and (downstream) 5Ј-CAACAGGTAGCATGCCC-CTGTC. Primer sequences included substitutions that incorporated restriction sites for XbaI and PaeI in the upstream and downstream primers, respectively. The PCR-generated fragment was subcloned into the XbaI-PaeI site of the vector pSEYC68 (pGal), which contains the GAL1/10 promoter cloned at the EcoRI-BamHI site.
JKG cells (Gal ϩ , leu2, ura3, trp1, his4) and JKG cells containing pGal-GPI10 (8) or pGal-MCD4 were grown to saturation in either YGal medium (2% (w/v) galactose, 1% (w/v) yeast extract, 2% (w/v) peptone, 40 mg/liter each of adenine, uracil, leucine, tryptophan, and histidine) or YPAUD medium (5% (w/v) glucose, 1% (w/v) yeast extract, 2% (w/v) peptone, 40 mg/liter each of adenine, uracil, leucine, tryptophan, and histidine). Plates containing 10 ml of YGal or YPAUD medium in 2.0% agar were spread with indicated amounts of YW3548 in 200 l of methanol. Serial 10-fold cell dilutions (5-l spots containing 10 1 -10 5 cells) were then applied to the plates. Growth was determined visually after 5 days of incubation at 30°C, with survivorship scored as the greatest cell dilution exhibiting growth.
RESULTS
Cloning, Characterization, and Disruption of Pig-n-We obtained a cDNA of Pig-n, a mouse Mcd4p homologue, from a testis library. The cDNA (4040 nucleotides not counting a poly(A) tract) encodes a 931-amino acid protein having the same number of amino acids as and 87% amino acid identity with human Mcd4p homologue (13) . It has 35% amino acid identity with yeast Mcd4p (13) . The GenBank TM accession number of Pig-n is AB030279. There was no information on chromosomal location of Pig-n in data bases, but human MCD4 homologue has been mapped to chromosome 18q21.2 (29) .
We then analyzed subcellular localization of Pig-n protein. For this, we transfected a cDNA of GST-tagged Pig-n into Pig-n knockout F9 cells. We used differential centrifugation to fractionate the cells into P10 (10,000 ϫ g pellet), P100 (100,000 ϫ g pellet), and S100 (100,000 ϫ g supernatant). GST-tagged Pig-n was detected mainly in P100, which contains plasma membrane, Golgi apparatus, and ER (Fig. 1A, lane 2) . Only small amounts were found in P10 containing mitochondria and lysosomes (Fig. 1A, lane 1) and S100 containing cytoplasm (lane 3). After further fractionation of P100 by sucrose density centrifugation, GST-tagged Pig-n was detected mainly in an ER-containing subfraction of P100, fraction 5 (Fig. 1B) .
Using the 5Ј region of Pig-n cDNA as a probe, we obtained 14 genomic clones, mapped them, and sequenced around the exons (GenBank TM accession numbers for the genomic sequences are AB030308 to AB030316). They contained 14 exons spanning about 25 kb that corresponded to only one-third of Pig-n cDNA at the 5Ј end, indicating that Pig-n gene has at least 15 exons (Fig. 2B, center) . The initiation codon was within exon 4. We constructed two targeting vectors to delete exons 8 and 9 ( Fig.  2A) , because they contained a region bearing homology to phosphodiesterases and nucleotide pyrophosphatases. After two successive homologous recombinations in F9 cells, Southern blotting and PCR analyses of genomic DNAs showed complete deletion of these exons (Fig. 2, C and D) . Because this disruption would cause a frameshift from exon 7, a double knockout mutant should not produce functional Pig-n protein.
Pig-n Is Required for the Addition of Phosphoethanolamine to Man1-To test whether Pig-n knockout cells lack the ability to add EtNP to Man1, we used a synthetic substrate, GlcN-PI(C8). It was reported that incubation of GlcN-PI(C8) with CHO cell membranes in the presence of palmitoyl-CoA and GDP-mannose resulted in inositol-acylation and mannosylation of the GlcN, generating Man-GlcN-(acyl)PI(C8) (19) . When we incubated GlcN-PI(C8) with membranes of F9 cells in the presence of palmitoyl-CoA and GDP-[ 3 H] mannose, GlcN-PI(C8) was converted to radiolabeled Man-GlcN-(acyl)PI(C8), termed H2(C8) (Fig. 3A, lanes 3 and 4) and further to a more polar product (marked H5(C8)). As shown in Fig. 3B , H2(C8) was sensitive to jack bean ␣-mannosidase, whereas H5(C8) was resistant (lanes 1 and 2) , which was consistent with the idea that H2(C8) was further modified by EtNP on mannose, generating H5(C8). This idea was also consistent with reports that synthetic dipalmitoyl GlcN-PI was converted to EtNP-ManGlcN-(acyl)PI in a similar cell-free system with HeLa cell membranes (30, 31) .
When membranes of Pig-n knockout F9 cells were used, GlcN-PI(C8) was converted to H2(C8) but not to H5(C8) (Fig.  3A, lanes 5 and 6) . This H2(C8) was sensitive to ␣-mannosidase, as expected (Fig. 3B, lanes 3 and 4) . Therefore, Pig-n knockout cells are defective in the transfer of EtNP to Man1.
To aid identification of endogenous mannolipids, we used membranes of Lec35 cells. Lec35 cells accumulate GlcN-(acyl)PI due to a defect in usage of dolichol phosphate mannose (18) . Upon incubation of the membrane with GDP-[
3 H]mannose, GlcN-(acyl)PI was efficiently converted to H2 (Man-GlcN-(acyl)PI), H4 (Man 3 -GlcN-(acyl)PI), and H5 (EtNP-Man-GlcN- , and S100 (lane 3). GST-tagged Pig-n was detected by Western blotting with anti-GST antibodies. B, the P100 fraction was further separated by sucrose density gradient centrifugation. Subfractions were characterized by assaying membrane marker enzyme activities (top panel). Squares, plasma membrane marker (alkaline phosphodiesterase I); triangles, Golgi marker (␣-mannosidase II); crosses, ER marker (dolichol phosphate mannose synthase); hatched bars, total proteins. GST-tagged Pig-n was detected by Western blotting (bottom panel).
FIG. 2.
A, targeting vectors for homologous recombinations. The first and second targeting vectors were designed to disrupt exons 8 and 9 and to contain the neomycin (neo) and puromycin (puro) resistance genes, respectively. HSV thymidine kinase gene (tk) was included at the 3Ј end to select against random integration. All selection marker genes were driven by PGK promoter and had PGK poly (acyl)PI) (Fig. 3A, lanes 1 and 2; see Fig. 4 for structures). GlcN-PI(C8) was also converted to H2(C8) and H5(C8) with membranes of Lec35 cells (Fig. 3A, lane 2) . Membranes of Pig-n knockout F9 cells accumulated more H2 and H4 than wild-type F9 membranes (Fig. 3A, lanes 3 and 5) . These profiles of endogenous mannolipids were also consistent with our conclusion that Pig-n knockout cells are defective in the transfer of EtNP to Man1.
Impaired GPI Biosynthesis in Pig-n Knockout F9 Cells-We next analyzed the biosynthesis of GPI anchor precursors in Pig-n knockout F9 cells (Fig. 5) . The Pig-n knockout F9 cells cultured in radiolabeled mannose had a different profile of mannolipids compared with wild-type F9 cells (Fig. 5, lanes 3  versus 5) . Mannolipids seen in the wild-type F9 cells (Fig. 5,  lane 3) were identified by comparing them with those in class B (lane 1) and class F (lane 2) mutant cells (15, 16, 32) (15, 32) . Class F cells are defective in the transfer of terminal EtNP (16, 32) and accumulated GPI bearing three mannoses with EtNP on Man1 (H6) and several other GPI species (Fig. 5, lane 2) . The Gaa1 knockout F9 cells (lane 4) accumulated various GPI intermediates due to a lack of GPI transamidase (see Fig. 4 for structures of GPI intermediates). The wild-type F9 cells had two major mannolipids H3 and H8, and several minor species (Fig. 5, lane 3) . H8 is a form of precursors of GPI anchor that can be transferred to proteins and has EtNP side chains on both Man1 and Man2 as well as the terminal EtNP on Man3. Unlike the wild-type cells, Pig-n knockout cells did not have H8, but instead had a major mannolipid with a higher mobility than H8 (Fig. 5, lane 5) . We termed this H7Ј because it was between positions of H8 and H7, another form of immediate precursors of GPI anchor bearing EtNP on Man1 and Man3. Below H7Ј, there was a minor new spot termed H7Љ (lane 5). The Pig-n knockout cells also had a prominent spot of H4 that was not seen in the wild-type cells (lanes 3 and 5) . Upon stable transfection of Pig-n cDNA into Pig-n knockout F9 cells, accumulation of H4 and H7Ј was greatly reduced, and H7Љ disappeared with the appearance of H8 (lane 6), indicating restoration of normal GPI biosynthesis. Incomplete disappearance of H4 and H7Ј was probably due to the presence of some cells that expressed the drug resistance gene but not Pig-n. Mock transfection did not restore normal GPI biosynthesis (lane 7).
To characterize H7Ј and H7Љ, which appeared after disruption of Pig-n, we treated mannolipids from Pig-n knockout cells with GPI-PLD and jack bean ␣-mannosidase (Fig. 6) . As a reference, we similarly treated mannolipids from Gaa1 knockout cells. Both H7Ј and H7Љ were sensitive to GPI-PLD, confirming that they are GPI species (Fig. 6A, lanes 3 and 4) . Similarly, H7 and H8 seen in Gaa1 knockout cells were sensitive to GPI-PLD (lanes 1 and 2) . H7 and H8 were resistant to ␣-mannosidase, as was expected (Fig. 6B, lanes 1 and 2) because their terminal mannoses bear EtNP. H7Ј was also resistant (lanes 3 and 4) , suggesting that its terminal mannose had EtNP. H3 and H4 were sensitive, consistent with their structures (Fig. 6B, lanes 2 and 4) . H7Љ, although it was faint (lane 1 and 3) . DPM, dolichol-phosphate-mannose. 3), was also sensitive. Based on these results, we speculate that H7Ј has three mannoses and EtNPs on Man 2 and Man3 but not on Man1, and that H7Љ has an extra mannose, Man4 (Fig.  4) . These speculated structures of most polar GPI species in Pig-n knockout cells are consistent with the idea that these cells are defective in the addition of EtNP to Man1 but still capable of generating further modified GPI species.
Surface Expression of GPI-anchored Proteins on Pig-n Knockout F9 Cells-Next, we assessed the surface expression of Thy-1, a GPI-anchored protein on Pig-n knockout cells. Double knockout cells still expressed Thy-1 on the cell surface (Fig. 7,  right panel) (8, 14) . To determine whether YW3548/BE49385A inhibits EtNP transfer to Man1 in mammalian cells, we tested its effect on modification of GlcN-PI(C8) by membranes of F9 and Chinese hamster ovary Lec35 cells. As shown in Fig. 8A , YW3548/ BE49385A inhibited generation of EtNP-Man-GlcN-(acyl)PI(C8), termed H5(C8), in a dose-dependent manner, whereas it did not inhibit generation of Man-GlcN-(acyl)PI(C8), termed H2(C8). When membranes of Lec35 cells were used, YW3548/BE49385A again inhibited generation of H5(C8) but not H2(C8) (Fig. 8B) . Lec35 membranes generated a detectable amount of endogenous Man-GlcN-(acyl)PI (H2), Man-Man-Man-GlcN-(acyl)PI (H4), and EtNP-ManGlcN-(acyl)PI, H5 (H4 and H5 were not well separated.). YW3548/BE49385A selectively inhibited generation of H5 with a slight increase of H2. We conclude that this drug inhibits EtNP addition to Man1 in mammalian cells.
We then tested the effect of YW3548/BE49385A on GPI biosynthesis in intact cells. Incubation of wild-type F9 cells with 10 M YW3548/BE49385A for 1 h had no effect (data not shown), so cells were kept with the drug for 24 h and then metabolically radiolabeled with [ 3 H]mannose (Fig. 9A) . The profile of mannolipids generated in the presence of the drug (lane 1) was very different from that of solvent-treated F9 cells (lane 2) but was nearly identical to that of Pig-n knockout F9 cells (lane 4). Moreover, the drug treatment had no effect on the profile of mannolipids in Pig-n knockout F9 cells (lane 3). These results indicate that YW3548/BE49385A inhibits the step at which Pig-n functions, i.e. transfer of EtNP to Man1. Consistent with the structures, H7, H8, and H8Ј were not generated in the presence of the drug in Gaa1 knockout F9 cells (lanes 5 and 6), whereas H7Јand H7Љ were generated (lane 5). Similarly, when class F cells were treated with the drug, GPI species bearing EtNP on Man1, such as H5, B, and H6, greatly decreased or disappeared (Fig. 9A, lanes 7 and 8) . However, YW3548/BE49385A did not cause the generation of H7Ј and H7Љ in class F cells (lane 7), indicating that their generation depends upon transfer of EtNP to Man3 and that Man3 in H7Ј and H7Љ is modified by EtNP.
The drug also affected GPI biosynthesis in human cells, causing disappearance of H8 and appearance of H7Ј, H4, H3, and H2 (Fig. 9A, lanes 9 and 10) . Another new species that appeared just above the H6 position may be EtNP-Man-ManMan-GlcN-(acyl)PI, an intermediate between H4 and H7Ј (see Fig. 4 for structures) .
These results suggest that the inhibition of EtNP transfer to Man1 by YW3548/BE49385A might not inhibit the surface expression of GPI-anchored proteins. We tested this by culturing human B lymphoblastoid JY25 cells in the presence of 10 2) and Pig-n knockout F9 (lanes 3 and 4) cells were treated with GPI-PLD (lanes 2 and 4) or buffer alone (lanes 1 and 3) overnight, and reextracted lipids were separated by TLC. B, the same lipids as in A were treated with jack bean ␣-mannosidase (lanes 2 and 4) or buffer alone (lanes 1 and 3) overnight.
M YW3548/BE49385A for 4 days and assessing the surface CD59 and DAF, GPI-anchored proteins, every day. As shown in Fig. 9B , the drug had almost no effect on the surface expression of DAF and only partially affected the surface expression of CD59.
Overexpression of MCD4 Renders Yeast Highly Resistant to YW3548/BE49385A-To examine whether the MCD4 gene product is a potential target of YW3548/BE49385A, we overexpressed the gene in yeast cells and examined their growth in the presence of the inhibitor. The full-length MCD4 sequence was cloned downstream of the GAL1/10 promoter in pSEYC68 (pGal), thus conferring galactose-dependent expression. Resistance was evident in cells grown with galactose, but not glucose, as the carbon source (Table I) . Overexpressing cells grown on plates spread with 50 g of YW3548/BE49385A exhibited only a 10% decrease in growth, whereas those expressing this gene at normal levels failed to establish visible colonies (Table I) . Moreover, cells overexpressing GPI10, which encodes the yeast PIG-B homologue and is required for addition of the third mannose during GPI anchor assembly, showed only slight resistance to YW3548/BE49385A (Table I ). The high degree of resistance exhibited by cells overexpressing MCD4 strongly points to the product of this gene as the likely target of the inhibitor.
DISCUSSION
In the present study, we characterized Pig-n, a mouse homologue of yeast Mcd4p, and demonstrated that it is involved in the transfer of EtNP to Man1 in GPI and that this modification of Man1 is not essential for further processing of GPI and its attachment to proteins. We also obtained evidence that Pig-n is a target of YW3548/BE49385A, an inhibitor of GPI biosynthesis.
In both mammalian and yeast cells, Man1 in GPI is modified by EtNP, whereas it is not modified in protozoa, such as T. brucei, L. major, and P. falciparum. Before this study, it was not clear whether this modification is an essential component of GPI of mammalian cells. MCD4 is essential for growth of Saccharomyces cerevisiae, and its temperature-sensitive mutant, mcd4 -174, does not generate functional GPI at nonpermissive temperatures (13) . This, taken together with our present result demonstrating that mammalian MCD4 homologue is involved in EtNP modification of Man1, indicate that the modification of Man1 is essential for generation of a sufficient amount of functional GPI in yeast. For mammalian cells, this modification seems less important because the surface expression of GPI-anchored proteins was only partially affected by disruption of Pig-n.
The current model of the GPI biosynthesis pathway in mammalian cells (10) is shown in Fig. 4 as pathway I. H2 is generated by transfer of Man1 to GlcN-(acyl)PI and then is converted to H5 with modification of Man1 by EtNP. Man2 and Man3 are added to generate H6 via B, followed by the addition of terminal EtNP to Man3, generating H7. The addition of EtNP to Man2 generates H8. H7 and H8 are thought to be transferred to proteins by GPI transamidase. In Gaa1 knockout cells, which are defective in GPI transamidase, a minor species, termed H8Ј, was also seen. Because H8Ј was sensitive to ␣-mannosidase, we assumed that it had Man4. H2 can be converted to H3 with the addition of Man2 without EtNP modification of Man1 because H3 was seen in wild-type cells. It is not certain whether Man1 in H3 can be modified with EtNP to generate B. When Pig-n is disrupted, the GPI species of pathway I, H5 through to H8Ј, would not be generated; instead, pathway II would operate. Pig-n knockout F9 cells accumulated H7Ј as well as H3 and H4. H7Љ was also seen. It is likely that H7Ј, H7Љ, and/or a putative precursor of H7Ј (between H4 and H7Ј in Fig. 4 ) are transferred to proteins.
MCD4 and GPI7, together with a gene for YLL031C open reading frame, form a gene family (12, 13) . Their gene products have 21-38% amino acid identity to each other and have similar domain organizations: an N-terminal hydrophilic lumenal domain and a C-terminal hydrophobic region containing multiple (10 -13) transmembrane domains. Within the N-terminal domain, they have a region that has homology to phosphodiesterases and nucleotide pyrophosphatases (12, 13 malian MCD4 homologue is involved in EtNP modification of Man1, it is tempting to speculate that Mcd4p, Gpi7p, and YLL031C are involved in EtNP modifications of Man1, Man2, and Man3, respectively. Furthermore, their homology to enzymes recognizing phosphodiesters raises the possibility that they have part of or the entire catalytic activity of EtNP transferases. Man1 is modified at position 2, whereas Man2 and Man3 are modified at position 6. Consistent with these different modification sites, Gpi7p and YLL031C share a higher amino acid identity (38%) than Gpi7p and Mcd4p (24%) and YLL031C and Mcd4p (21%) (12) .
Mammalian class F mutant cells are defective in transfer of EtNP to Man3 (16, 32) , and the PIG-F gene is responsible for this modification (33) . The PIG-F protein is very hydrophobic (33) and is localized to the ER. 2 S. cerevisiae has a PIG-F homologue, YDR302W, but there is no other homologous open reading frame. If both the PIG-F homologue and YLL031C are involved in the transfer of EtNP to Man3, it will be interesting to clarify their roles.
YW3548/BE49385A, a natural terpenoid produced by fungi, kills yeast S. cerevisiae at micromolar concentrations by inhibiting GPI synthesis (14) . In the presence of this drug, ManMan-GlcN-(acyl)PI was accumulated in yeast (14) . Because EtNP modification of Man1 in yeast was not known at the time of the study, it was thought that YW3548/BE49385A inhibited transfer of Man3. Later, EtNP modification of Man1 in yeast and accumulation of Man-(EtNP)Man-GlcN-(acyl)PI in yeast that is defective in transfer of Man3 were demonstrated (8, 9) , suggesting that YW3548/BE49385A inhibits EtNP modification of Man1 and that Man2 was added without this modification (8) . Consistent with this, in this study we found that YW3548/BE49385A inhibits EtNP modification of Man1 in mammalian cells. The importance of this modification is different in yeast and mammalian cells: it is essential for growth of yeast but dispensable for the surface expression of GPI-anchored proteins on mammalian cells.
These different extents of requirement of the EtNP modification of Man1 in yeast and mammalian cells would be accounted for by the substrate specificity of enzymes for the downstream steps. Particularly, the Man3 transferase seems to be at least partly responsible. In yeast treated with YW3548/ BE49385A, Man2-bearing GPI was accumulated (14) , indicating that transfer of Man2 occurred without the Man1 modification and that its conversion to Man3-bearing GPI was severely affected. Therefore, yeast Man3 transferase, probably Gpi10p (8), did not use Man-Man-GlcN-(acyl)PI efficiently as a substrate, resulting in a lack of a sufficient amount of functional GPI. A similar situation would exist when MCD4 is disrupted. Consistent with this, overexpression of GPI10 gave partial resistance to YW3548/BE49385A (8) . In contrast, H4 (Man-Man-Man-GlcN-(acyl)PI) and other pathway II intermediates, such as H7Ј and H7Љ (Fig. 4) , were clearly seen when the F9 cells were treated with YW3548/BE49385A (Fig. 9A, lane 1) , as well as when Pig-n was disrupted (Fig. 5, lane 5) . Therefore, mammalian Man3 transferase, probably PIG-B, would use ManMan-GlcN-(acyl)PI more efficiently than the yeast counterpart.
Yeasts overexpressing MCD4 were highly resistant to YW3548/BE49385A, strongly suggesting that Mcd4p and its mammalian homologue Pig-n are targets of this drug. Because EtNP modification of Man1 is essential for growth of yeast but is dispensable for the surface expression of GPI-anchored proteins on mammalian cells, YW3548/BE49385A would be useful for selectively inhibiting the generation of GPI-anchored proteins in yeast and perhaps other fungi.
